CTX Lifesciences Pvt. Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- 251-252, Sachin Magdalla Road, GIDC Sachin,, Surat, Gujarat 394230, India (IND)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3006254924 · DUNS 676190180
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-09-02
- VAIDrug Quality Assurance2018-01-30
- OAIDrug Quality Assurance2016-02-19
- VAIDrug Quality Assurance2012-12-30
- VAIDrug Quality Assurance2009-11-06
Drugs this plant is listed as making
1 distinct drugs across 3 products name this site in their FDA label.
- metoprolol succinateCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.